Fig. 3From: Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry iceUC-MSCs immunomodulation properties. The anti-proliferative activity of UC-MSCs was analysed by flow cytometry after PBMC labelling with CFSE. Statistical significance is relative to the proliferation of activated lymphocytes in the absence of MSCs (n = 3) (*p < 0.05; ** p < 0.01)Back to article page